A Phase 1 study of IRDye800CW-nimotuzumab in lung cancer surgery

Recruiting Phase 1,Phase 2 NCT04459065

Study Description

Evaluating a new imaging probe to help detect lung cancer during surgery

Study Details

Registry ID:
NCT04459065
Conditions:
Lung Cancer
Phase:
Phase 1,Phase 2
Target Enrollment:
36 participants
Start Date:
Age Range:
18–80 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →